Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04625270Phase 2Active Not Recruiting
A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation
Low Grade Ovarian Serous AdenocarcinomaOvarian Cancer
PrincipalinvestigatorStart date: 2020-12-21

Research Network

Collaboration Network

5 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

European Network of Gynaecological Oncological Trial Groups (ENGOT)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

MD Verastem

Verastem, Inc.

Moderately Similar
5 trials

Shared therapeutic areas:

Low Grade Ovarian Serous AdenocarcinomaOvary CancerRecurrent Low-Grade Serous Ovarian Cancer (LGSOC)

Worked with same sponsors:

European Network of Gynaecological Oncological Trial Groups (ENGOT)GOG Foundation+1 more
Collaborated on 1 trial
Similarity Score34%

Rachel Grisham, MD

GOG Foundation

Moderately Similar
2 trials

Shared therapeutic areas:

Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)Low Grade Ovarian Serous AdenocarcinomaOvary Cancer

Worked with same sponsors:

European Network of Gynaecological Oncological Trial Groups (ENGOT)GOG Foundation+1 more
Collaborated on 1 trial
Similarity Score34%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score10%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score10%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score10%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Ovary Cancer

Worked with same sponsors:

Verastem, Inc.
Similarity Score10%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score10%

Sandro Pignata, M.D., Ph.D.

National Cancer Institute, Naples

Related
9 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score10%

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Related
12 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04625270Phase 2PrincipalInvestigator

A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation

Low Grade Ovarian Serous AdenocarcinomaOvarian Cancer
Active Not Recruiting

All 1 trials loaded